Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechSci Research | PRODUCT CODE: 1703273

Cover Image

PUBLISHER: TechSci Research | PRODUCT CODE: 1703273

Probiotics Dietary Supplements Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Form, By End-use, By Applications, By Region, & Competition, 2020-2030F

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4500
PDF and Excel (Multi-User License)
USD 5500
PDF and Excel (Custom Research License)
USD 8000

Add to Cart

We offer 8 hour analyst time for an additional research. Please contact us for the details.

The Global Probiotics Dietary Supplements Market was valued at USD 8.76 billion in 2024 and is projected to achieve strong growth over the forecast period, with a compound annual growth rate (CAGR) of 10.75% through 2030.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 8.76 Billion
Market Size 2030USD 16.20 Billion
CAGR 2025-203010.75%
Fastest Growing SegmentTablets and Softgels
Largest MarketNorth America

The market is experiencing accelerated expansion, driven by a clear shift in consumer behavior toward scientifically validated and proactive approaches to health management. Probiotics-live microbial strains with clinically proven benefits for gut and immune health-are becoming an integral component of evidence-based nutritional strategies across a broad range of consumer demographics.

This growing adoption is closely tied to the increasing prevalence of lifestyle-related health conditions, including gastrointestinal disorders, weakened immune response, and chronic inflammation-particularly among adults and aging populations. Consumers are gravitating toward natural, non-pharmaceutical alternatives, fueling demand for probiotic products that align with clean-label principles and preventive wellness practices.

Key Market Drivers

Rising Prevalence of Gastrointestinal and Lifestyle-Related Disorders

The surge in gastrointestinal (GI) and lifestyle-related disorders is a key growth driver for the probiotics dietary supplements market. Non-communicable diseases (NCDs), which include many of these disorders, have become the dominant global health challenge, accounting for approximately 75% of all non-pandemic-related deaths. In 2021, NCDs were responsible for over 43 million deaths worldwide, with cardiovascular conditions leading the count.

This shift has influenced both consumer behavior and healthcare priorities, positioning probiotics as an essential element of preventive and therapeutic strategies focused on gut health and overall well-being. Digestive issues such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), acid reflux, constipation, and bloating are increasingly common across various age groups and geographies, further driving demand for probiotic supplementation.

Key Market Challenges

Quality Control and Product Standardization

Maintaining the quality, efficacy, and stability of probiotic supplements remains a significant challenge. As live microorganisms, probiotics must remain viable throughout the entire production, packaging, storage, and distribution cycle. Any degradation in potency can result in inconsistent health outcomes and potentially undermine consumer confidence. Ensuring stringent quality standards and formulation integrity is therefore critical for sustained market growth and credibility.

Key Market Trends

Emergence of Personalized Nutrition

The growing demand for individualized health solutions is reshaping the probiotics landscape. Personalized nutrition-including custom probiotic formulations-is gaining momentum as consumers increasingly seek products tailored to their unique physiological needs. Innovations such as DNA testing and microbiome analysis are enabling the identification of specific probiotic strains that deliver targeted benefits based on individual health profiles, paving the way for highly personalized and effective wellness interventions.

Key Market Players

  • Vitakem Nutraceutical Inc
  • Lesaffre International Corp
  • DuPont de Nemours Inc
  • H&H Group PLC
  • Amway Corp
  • Abbott Laboratories Inc
  • Bayer AG
  • Pfizer Inc.
  • GSK PLC
  • BASF SE

Report Scope:

In this report, the Global Probiotics Dietary Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Probiotics Dietary Supplements Market, By Form:

  • Chewables & Gummies
  • Capsules
  • Powders
  • Tablets & Softgels
  • Others

Probiotics Dietary Supplements Market, By End-Use:

  • Infants
  • Children
  • Adults
  • Geriatric

Probiotics Dietary Supplements Market, By Application:

  • Sports Fitness
  • Energy & Weight Management
  • General Health
  • Bone & Joint Health
  • Gastrointestinal Health
  • Immunity
  • Cardiac Health
  • Diabetes
  • Anti-cancer
  • Skin/Hair/Nails
  • Brain/Mental Health
  • Others

Probiotics Dietary Supplements Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Probiotics Dietary Supplements Market.

Available Customizations:

Global Probiotics Dietary Supplements market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Product Code: 16421

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Probiotics Dietary Supplements Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
    • 5.2.2. By End-use (Infants, Children, Adults, Geriatric)
    • 5.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Product Market Map

6. North America Probiotics Dietary Supplements Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
    • 6.2.2. By End-use (Infants, Children, Adults, Geriatric)
    • 6.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Probiotics Dietary Supplements Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Form
        • 6.3.1.2.2. By End-use
        • 6.3.1.2.3. By Applications
    • 6.3.2. Canada Probiotics Dietary Supplements Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Form
        • 6.3.2.2.2. By End-use
        • 6.3.2.2.3. By Applications
    • 6.3.3. Mexico Probiotics Dietary Supplements Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Form
        • 6.3.3.2.2. By End-use
        • 6.3.3.2.3. By Applications

7. Europe Probiotics Dietary Supplements Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
    • 7.2.2. By End-use (Infants, Children, Adults, Geriatric)
    • 7.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Probiotics Dietary Supplements Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Form
        • 7.3.1.2.2. By End-use
        • 7.3.1.2.3. By Applications
    • 7.3.2. United Kingdom Probiotics Dietary Supplements Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Form
        • 7.3.2.2.2. By End-use
        • 7.3.2.2.3. By Applications
    • 7.3.3. France Probiotics Dietary Supplements Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Form
        • 7.3.3.2.2. By End-use
        • 7.3.3.2.3. By Applications
    • 7.3.4. Italy Probiotics Dietary Supplements Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Form
        • 7.3.4.2.2. By End-use
        • 7.3.4.2.3. By Applications
    • 7.3.5. Spain Probiotics Dietary Supplements Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Form
        • 7.3.5.2.2. By End-use
        • 7.3.5.2.3. By Applications

8. Asia-Pacific Probiotics Dietary Supplements Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
    • 8.2.2. By End-use (Infants, Children, Adults, Geriatric)
    • 8.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Probiotics Dietary Supplements Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Form
        • 8.3.1.2.2. By End-use
        • 8.3.1.2.3. By Applications
    • 8.3.2. Japan Probiotics Dietary Supplements Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Form
        • 8.3.2.2.2. By End-use
        • 8.3.2.2.3. By Applications
    • 8.3.3. India Probiotics Dietary Supplements Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Form
        • 8.3.3.2.2. By End-use
        • 8.3.3.2.3. By Applications
    • 8.3.4. Australia Probiotics Dietary Supplements Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Form
        • 8.3.4.2.2. By End-use
        • 8.3.4.2.3. By Applications
    • 8.3.5. South Korea Probiotics Dietary Supplements Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Form
        • 8.3.5.2.2. By End-use
        • 8.3.5.2.3. By Applications

9. South America Probiotics Dietary Supplements Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
    • 9.2.2. By End-use (Infants, Children, Adults, Geriatric)
    • 9.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Probiotics Dietary Supplements Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Form
        • 9.3.1.2.2. By End-use
        • 9.3.1.2.3. By Applications
    • 9.3.2. Argentina Probiotics Dietary Supplements Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Form
        • 9.3.2.2.2. By End-use
        • 9.3.2.2.3. By Applications
    • 9.3.3. Colombia Probiotics Dietary Supplements Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Form
        • 9.3.3.2.2. By End-use
        • 9.3.3.2.3. By Applications

10. Middle East and Africa Probiotics Dietary Supplements Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
    • 10.2.2. By End-use (Infants, Children, Adults, Geriatric)
    • 10.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Probiotics Dietary Supplements Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Form
        • 10.3.1.2.2. By End-use
        • 10.3.1.2.3. By Applications
    • 10.3.2. Saudi Arabia Probiotics Dietary Supplements Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Form
        • 10.3.2.2.2. By End-use
        • 10.3.2.2.3. By Applications
    • 10.3.3. UAE Probiotics Dietary Supplements Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Form
        • 10.3.3.2.2. By End-use
        • 10.3.3.2.3. By Applications
    • 10.3.4. Kuwait Probiotics Dietary Supplements Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Form
        • 10.3.4.2.2. By End-use
        • 10.3.4.2.3. By Applications

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Vitakem Nutraceutical Inc
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Lesaffre International Corp
  • 14.3. DuPont de Nemours Inc
  • 14.4. H&H Group PLC
  • 14.5. Amway Corp
  • 14.6. Abbott Laboratories Inc
  • 14.7. Bayer AG
  • 14.8. Pfizer Inc.
  • 14.9. GSK PLC
  • 14.10. BASF SE

15. Strategic Recommendations

16. About Us & Disclaimer

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!